AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CARCLO PLC

AGM Information Feb 25, 2015

5252_dva_2015-02-25_d787f77d-b80f-40bf-8ba8-9cf42bcccaeb.html

AGM Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 8823F

Carclo plc

25 February 2015

For immediate release                                                                         

25 February 2015

Carclo plc

("Carclo" or the "Group")

Result of General Meeting

On 5 February 2015, the board of directors of the Company announced the Company's intention to seek shareholder approval to cancel the Company's share premium account and capital redemption reserve at the Company's General Meeting to be held on 25 February 2015 ("Cancellations"). A committee of the Company's board of directors was established by a board resolution passed on 29 January 2015 ("Committee"). Notice of the General Meeting together with copies of the circular and form of proxy were posted to the Company's shareholders on 9 February 2015.

The Committee is pleased to announce that at the General Meeting, held today at 15:30pm, the Cancellations were formally approved by the Company's shareholders and the resolution to provide implementation of the Cancellations was duly passed.

- ENDS -

Enquiries:

Carclo plc 01924 268040
Chris Malley, Chief Executive
Robert Brooksbank, Finance Director
Peel Hunt LLP 0207 418 8900
Justin Jones
Jock Maxwell Macdonald
Mike Bell
N+1 Singer

Shaun Dobson

Richard Lindley
0207 496 3000
Weber Shandwick

Nick Oborne

Tom Jenkins
0207 067 0000

Notes to editors

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins the group has been investing in new technologies.

Approximately three fifths of revenues are currently derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

This information is provided by RNS

The company news service from the London Stock Exchange

END

ROMEELFLELFZBBK

Talk to a Data Expert

Have a question? We'll get back to you promptly.